North America holds a significant share of the choledocholithiasis market due to its well-established healthcare systems, growing incidence of biliary disorders, and increasing use of advanced imaging and endoscopic technologies. Rising healthcare expenditure, expanding access to specialized gastrointestinal treatment, and ongoing technological innovation continue to support steady market...